Financhill
Sell
39

RYN Quote, Financials, Valuation and Earnings

Last price:
$21.51
Seasonality move :
2.68%
Day range:
$21.40 - $21.71
52-week range:
$21.06 - $32.07
Dividend yield:
6.75%
P/E ratio:
8.86x
P/S ratio:
3.06x
P/B ratio:
1.45x
Volume:
1.3M
Avg. volume:
1.5M
1-year change:
-31.15%
Market cap:
$3.3B
Revenue:
$1.3B
EPS (TTM):
$2.43

Earnings Data

Next earnings date for RYN
Feb 04
2026
Most recent earnings per share
$0.28
Beat by $0.06
(Nov 5/2025)
Consensus Estimate
$0.22
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RYN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/04/2026 Q4 $107.9M -- -- $0.13 --
11/05/2025 Q3 $162.3M $177.5M $0.28 $0.22 $0.06
08/06/2025 Q2 $95.3M $106.5M $0.03 $0.02 $0.00
04/30/2025 Q1 $153.1M $82.9M -$0.02 $0.08 -$0.10
02/05/2025 Q4 $207.3M $726.3M $2.15 $0.20 $1.95
11/06/2024 Q3 $211.2M $195M $0.19 $0.13 $0.06
08/07/2024 Q2 $218.9M $99.6M $0.01 $0.14 -$0.12
05/01/2024 Q1 $190M $113.7M $0.01 $0.04 -$0.03
02/01/2024 Q4 $232.4M $467.4M $0.84 $0.15 $0.68
11/01/2023 Q3 $207.6M $201.6M $0.13 $0.12 $0.01
08/02/2023 Q2 -- $208.9M $0.13 -- --
05/03/2023 Q1 -- $179.1M $0.06 -- --
02/01/2023 Q4 -- $245.4M $0.22 -- --
11/02/2022 Q3 -- $195.3M $0.14 -- --
08/03/2022 Q2 -- $246.3M $0.16 -- --
05/04/2022 Q1 -- $222M $0.20 -- --
02/02/2022 Q4 -- $262M $0.06 -- --
11/03/2021 Q3 -- $364.7M $0.53 -- --
08/04/2021 Q2 -- $753K $0.41 -- --
05/05/2021 Q1 -- $1.8M $0.08 -- --
02/03/2021 Q4 -- $205.5M $0.07 -- --
10/28/2020 Q3 -- $198.2M -$0.01 -- --
08/05/2020 Q2 -- $193.7M $0.01 -- --
04/29/2020 Q1 -- $259.2M $0.20 -- --
02/05/2020 Q4 -- $179.5M $0.12 -- --
10/30/2019 Q3 -- $157.2M -$0.00 -- --
08/07/2019 Q2 -- $185M $0.14 -- --
05/01/2019 Q1 -- $191.1M $0.19 -- --
02/06/2019 Q4 -- $166.9M $0.02 -- --
10/31/2018 Q3 -- $201.7M $0.18 -- --
08/01/2018 Q2 -- $245.5M $0.28 -- --
05/02/2018 Q1 -- $201.8M $0.31 -- --
02/07/2018 Q4 -- $260.7M $0.50 -- --
11/01/2017 Q3 -- $182.9M $0.19 -- --
08/02/2017 Q2 -- $199.4M $0.20 -- --
05/03/2017 Q1 -- $193.8M $0.27 -- --
02/08/2017 Q4 -- $221.1M $0.39 -- --
11/03/2016 Q3 -- $171.1M $0.32 -- --
08/03/2016 Q2 -- $261.6M $0.89 -- --
05/04/2016 Q1 -- $135.7M $0.12 -- --
02/11/2016 Q4 -- $139.4M $0.08 -- --

Rayonier, Inc. Earnings Questions

  • How Much did Rayonier, Inc. Generate in Revenue Last Quarter?

    Rayonier, Inc. reported $177.5M worth of top line sales in its most recent quarter.

  • Did Rayonier, Inc. Beat Earnings Last Quarter?

    Rayonier, Inc. announced earnings per share of $0.28 which represents a beat of analyst forecast a $0.22 per share.

  • Is Rayonier, Inc. Profitable?

    Rayonier, Inc. reported $58.4M that represents $0.37 per share over the last quarter.

  • What is the Analyst Consensus for Rayonier, Inc. EPS Next Year?

    Rayonier, Inc.'s earnings are forecast to decrease from $2.39 per share to $0.50 per share next year representing a decrease of -79.12%.

  • When is Rayonier, Inc.'s Earnings Date?

    Rayonier, Inc.'s next earnings date is February 4, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 6

SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.

Buy
62
PRAX alert for Dec 6

Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.

Sell
13
PSN alert for Dec 6

Parsons Corp. [PSN] is down 21.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock